Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correlation Between Quantitative Pupillometry and Other Markers for Neuroprognostication of Comatose Patients After Cardiac Arrest: A Bicentric Study.

Critical care medicine·2026

Same author

Status Epilepticus Is Detected Earlier than Seizures on cEEG in Critically Ill Adults.

Neurocritical care·2026

Same author

Effects of midazolam and propofol on EEG detection of epileptiform activity in patients with altered consciousness.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026

Same author

Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring.

Critical care medicine·2026

Same author

Brainstem Respiratory Center Dysfunction in Persons With Epilepsy: An fMRI Study.

Neurology·2026

Same author

Relevance of EEG recording time for juvenile myoclonic epilepsy diagnosis confirmation: a reappraisal.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026

Same journal

Revue medicale suisse·2026

Same journal

Revue medicale suisse·2026

Same journal

Revue medicale suisse·2026

Same journal

Revue medicale suisse·2026

Same journal

Revue medicale suisse·2026

Same journal

Revue medicale suisse·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 30, 2026

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

[Neurology].

Elissavet Eskioglou¹, David Benninger¹, Gabriella Di Virgilio¹

¹Service de neurologie, Département des neurosciences cliniques, CHUV, 1011 Lausanne.

Revue Medicale Suisse

|January 11, 2019

Summary

This summary is machine-generated.

New therapeutic strategies show promise for neurological disorders. These include advanced treatments for stroke, migraine, multiple sclerosis, epilepsy, Alzheimer's disease, Parkinson's disease, and myasthenia gravis, improving patient outcomes.

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Related Experiment Videos

Last Updated: Jan 30, 2026

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Area of Science:

Neurology
Neuroscience
Medical Imaging

Background:

Advancements in medical imaging facilitate timely interventions for conditions like stroke.
Emerging therapies offer new hope for managing chronic neurological diseases.
Understanding disease mechanisms is crucial for developing targeted treatments.

Purpose of the Study:

To review recent developments in the treatment of various neurological conditions.
To highlight the efficacy of novel therapeutic approaches.
To provide an overview of current best practices and future directions in neurology.

Main Methods:

Literature review of recent studies on neurological treatments.
Analysis of clinical trial data for novel therapies.
Synthesis of information on diagnostic criteria and treatment efficacy.

Main Results:

Thrombolysis and late thrombectomy are viable for stroke with appropriate imaging.
Anti-CGRP monoclonal antibodies demonstrate high efficacy in migraine treatment.
Siponimod significantly reduces disability progression in secondary progressive multiple sclerosis (MS).
Switching to generic levetiracetam does not trigger epileptic seizures.
Biomarker-based definitions of Alzheimer's disease enhance mechanistic understanding.
Levodopa-carbidopa intestinal gel and apomorphine infusion reduce motor fluctuations in Parkinson's disease.
Eculizumab serves as an alternative for severe myasthenia gravis.

Conclusions:

Recent therapeutic advancements offer improved management options for diverse neurological disorders.
Personalized medicine approaches, guided by biomarkers and imaging, are transforming neurological care.
The reviewed treatments represent significant progress in addressing unmet needs in neurology.